Výsledky vyhledávání - "Guilluame Luxardi"

Supplemental Figure 3 from Long-term Follow-up and Correlative Analysis of Two Phase II Trials of Rituximab and Lenalidomide Followed by Continuous Lenalidomide in Untreated and Relapsed/Refractory Indolent Lymphoma

Autor: Emanual Maverakis, Brian Jonas, Aaron Rosenberg, Ann Brunson, Alina Marusina, Alexander Merleev, Guilluame Luxardi, Paul Kaesberg, Christina Poh, Joseph M. Tuscano

Flow cytometric analysis of NK, NK T cell and Treg subpopulations.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a6f533332f37877c2877c9f23e95739
https://doi.org/10.1158/1078-0432.22481073

Zobrazit plný text záznamu

Supplementary Data from Long-term Follow-up and Correlative Analysis of Two Phase II Trials of Rituximab and Lenalidomide Followed by Continuous Lenalidomide in Untreated and Relapsed/Refractory Indolent Lymphoma

Autor: Emanual Maverakis, Brian Jonas, Aaron Rosenberg, Ann Brunson, Alina Marusina, Alexander Merleev, Guilluame Luxardi, Paul Kaesberg, Christina Poh, Joseph M. Tuscano

Supplemental figure legends

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02e93b9581b7dffc87483e034fdcb860
https://doi.org/10.1158/1078-0432.22481061

Zobrazit plný text záznamu

Supplemental Figure 2 from Long-term Follow-up and Correlative Analysis of Two Phase II Trials of Rituximab and Lenalidomide Followed by Continuous Lenalidomide in Untreated and Relapsed/Refractory Indolent Lymphoma

Autor: Emanual Maverakis, Brian Jonas, Aaron Rosenberg, Ann Brunson, Alina Marusina, Alexander Merleev, Guilluame Luxardi, Paul Kaesberg, Christina Poh, Joseph M. Tuscano

Gating strategy for analysis of live lymphocytes.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::134fab36cf5b24143427c8d4a45bbb2a
https://doi.org/10.1158/1078-0432.22481076.v1

Zobrazit plný text záznamu

Supplemental Figure 1 from Long-term Follow-up and Correlative Analysis of Two Phase II Trials of Rituximab and Lenalidomide Followed by Continuous Lenalidomide in Untreated and Relapsed/Refractory Indolent Lymphoma

Autor: Emanual Maverakis, Brian Jonas, Aaron Rosenberg, Ann Brunson, Alina Marusina, Alexander Merleev, Guilluame Luxardi, Paul Kaesberg, Christina Poh, Joseph M. Tuscano

Plasma cytokine levels of LTCR responders compared to all other patients.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58e850cd6b05fb502609affcad16825a
https://doi.org/10.1158/1078-0432.22481079.v1

Zobrazit plný text záznamu

Data from Long-term Follow-up and Correlative Analysis of Two Phase II Trials of Rituximab and Lenalidomide Followed by Continuous Lenalidomide in Untreated and Relapsed/Refractory Indolent Lymphoma

Autor: Emanual Maverakis, Brian Jonas, Aaron Rosenberg, Ann Brunson, Alina Marusina, Alexander Merleev, Guilluame Luxardi, Paul Kaesberg, Christina Poh, Joseph M. Tuscano

Purpose:Rituximab and lenalidomide are effective for previously untreated and relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL). However, long-term survival and predictive biomarkers are not well described.Patients and Methods:We conduct

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92c2f0818dd4c424b096166ca61e71b9
https://doi.org/10.1158/1078-0432.c.6530610.v1

Zobrazit plný text záznamu

Long-term Follow-up and Correlative Analysis of Two Phase II Trials of Rituximab and Lenalidomide Followed by Continuous Lenalidomide in Untreated and Relapsed/Refractory Indolent Lymphoma

Autor: Alexander A. Merleev, Paul Kaesberg, Guilluame Luxardi, Brian A. Jonas, Christina Poh, Joseph Tuscano, Aaron S. Rosenberg, Alina I. Marusina, Emanual Michael Maverakis, Ann Brunson

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research, vol 27, iss 17

Purpose: Rituximab and lenalidomide are effective for previously untreated and relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL). However, long-term survival and predictive biomarkers are not well described. Patients and Methods: We cond

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36612ff8712100eac66aba39283ee736
https://escholarship.org/uc/item/0qq2r4sb

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání